On March 23, 2017, Soeberdt, Michael; Molenveld, Peter; Storcken, Roy P. M.; Bouzanne des Mazery, Renaud; Sterk, Geert Jan; Autar, Reshma; Bolster, Marjon G.; Wagner, Clemens; Aerts, Sebastianus N. H.; van Holst, Frank R.; Wegert, Anita; Tangherlini, Giovanni; Frehland, Bastian; Schepmann, Dirk; Metze, Dieter; Lotts, Tobias; Knie, Ulrich; Lin, Kun-Yuan; Huang, Tai-Yu; Lai, Chih-Ching; Staender, Sonja; Wuensch, Bernhard; Abels, Christoph published an article.Quality Control of 5,6,7,8-Tetrahydroquinoxaline The title of the article was Design and Synthesis of Enantiomerically Pure Decahydroquinoxalines as Potent and Selective κ-Opioid Receptor Agonists with Anti-Inflammatory Activity in Vivo. And the article contained the following:
In order to develop novel κ agonists restricted to the periphery, a diastereo- and enantioselective synthesis of (4aR,5S,8aS)-configured decahydroquinoxalines was developed. Physicochem. and pharmacol. properties were fine-tuned by structural modifications in the arylacetamide and amine part of the pharmacophore as well as in the amine part outside the pharmacophore. The decahydroquinoxalines show single-digit nanomolar to subnanomolar κ-opioid receptor affinity, full κ agonistic activity in the [35S]GTPγS assay, and high selectivity over μ, δ, σ1, and σ2 receptors as well as the PCP binding site of the NMDA receptor. Several analogs were selective for the periphery. The anti-inflammatory activity of decahydroquinoxalines after topical application was investigated in two mouse models of dermatitis. The methanesulfonamide I containing the (S)-configured hydroxypyrrolidine ring was identified as potent (Ki = 0.63 nM) and highly selective, κ agonist (EC50 = 1.8 nM) selective for the periphery with dose-dependent anti-inflammatory activity in acute and chronic skin inflammation. The experimental process involved the reaction of 5,6,7,8-Tetrahydroquinoxaline(cas: 34413-35-9).Quality Control of 5,6,7,8-Tetrahydroquinoxaline
The Article related to decahydroquinoxaline stereoselective preparation opioid receptor agonistic antiinflammatory activity, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazines and Quinoxalines (Including Piperazines) and other aspects.Quality Control of 5,6,7,8-Tetrahydroquinoxaline
Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider